NICE has developed a medtech innovation briefing (MIB) on the Alere Afinion CRP for C-reactive protein testing in primary care. MIBs provide a description of the medical technology, including its ...

BANGALORE/LONDON, Aug 24 (Reuters) - Axis-Shield , the British medical diagnostics firm fighting a takeover by U.S. rival Alere Inc , is open to considering an offer that values the company "more ...

ALERE, the US healthcare giant, yesterday extended the closing date for its unsolicited £230 million takeover offer for Scottish-Norwegian medical diagnostics kit maker Axis-Shield by about two weeks.

(Reuters) - U.S. medical diagnostics firm Alere Inc said it raised its stake in smaller UK peer Axis-Shield to 29.9 percent, the most it can buy in the open market, pushing a potential rival bidder to ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The chief executive of Axis-Shield has accused Alere of attempting to “get the company on the cheap” after the ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Alere has intensified pressure on Axis-Shield shareholders to accept its £230m hostile takeover bid by ...

Good morning, and welcome to the Alere Inc First Quarter 2015 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will ...

The misuse of antibiotics has led to microorganisms mutating or acquiring resistance genes that empower them to resist antimicrobial treatments, which were earlier effective. In the 2013 Global Risks ...

A literature search was carried out for this briefing in accordance with the published process and methods statement. This briefing includes the most relevant or best available published evidence ...